Michael S. Baum
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- Global Cancer Incidence and Screening
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
Papers in
- Cancer Research 126
- Breast Cancer Treatment Studies 119
- Oncology 138
- Global Cancer Incidence and Screening 57
- Cancer Treatment and Pharmacology 27
- Colorectal Cancer Screening and Detection 27
- Co-authors
- Lesley J. Fallowfield (18 shared papers)Jack M. Cuzick (12 shared papers)Mitch Dowsett (14 shared papers)Anthony Howell (9 shared papers)G. P. Maguire (6 shared papers)Aman U. Buzdar (7 shared papers)J. Houghton (17 shared papers)John Forbes (5 shared papers)
- Journals
- The Lancet (59 papers)European Journal of Cancer (19 papers)British Journal of Cancer (19 papers)British journal of surgery (16 papers)Journal of Clinical Oncology (11 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Michael S. Baum
353 papers receiving 15.9k citations
Michael S. Baum's Hit Papers
Peers
Comparison fields: 5 of 190
- Cancer Research 6.7k
- Oncology 5.5k
- Radiation 957
- Genetics 2.8k
- Pathology and Forensic Medicine 1.5k
Countries citing papers authored by Michael S. Baum
This map shows the geographic impact of Michael S. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Baum more than expected).
Fields of papers citing papers by Michael S. Baum
This network shows the impact of papers produced by Michael S. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Baum. The network helps show where Michael S. Baum may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael S. Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 371 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Hit paper breakdown → | 2010 | 1213 |
| 2 | Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. Hit paper breakdown → | 1994 | 755 |
| 3 | Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial Hit paper breakdown → | 2013 | 664 |
| 4 | Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen Hit paper breakdown → | 2009 | 652 |
| 5 | Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. Hit paper breakdown → | 1990 | 651 |
| 6 | First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial Hit paper breakdown → | 2002 | 607 |
| 7 | 2010 | 607 | |
| 8 | Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study Hit paper breakdown → | 2010 | 597 |
| 9 | Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Hit paper breakdown → | 2011 | 490 |
| 10 | 2008 | 328 | |
| 11 | Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. | 1992 | 315 |
| 12 | 1986 | 289 | |
| 13 | 1990 | 288 | |
| 14 | 1988 | 271 | |
| 15 | 2009 | 257 | |
| 16 | 2006 | 233 | |
| 17 | 2005 | 211 | |
| 18 | 2020 | 207 | |
| 19 | 2001 | 194 | |
| 20 | 1994 | 176 |
About Michael S. Baum
Michael S. Baum is a scholar working on Cancer Research, Oncology, Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 371 papers that have together received 16.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (119 papers), Estrogen and related hormone effects (59 papers), Global Cancer Incidence and Screening (57 papers), BRCA gene mutations in cancer (34 papers), Cancer Treatment and Pharmacology (27 papers), Colorectal Cancer Screening and Detection (27 papers), Breast Lesions and Carcinomas (23 papers) and Advances in Oncology and Radiotherapy (17 papers). The work is most often cited by research in Cancer Research (6.7k citations), Oncology (5.5k citations), Radiation (957 citations), Genetics (2.8k citations) and Pathology and Forensic Medicine (1.5k citations). Michael S. Baum has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Lesley J. Fallowfield, Jack M. Cuzick, Mitch Dowsett, Anthony Howell, G. P. Maguire, Aman U. Buzdar, J. Houghton, John Forbes, Angela S. Hall and William J.M. Hrushesky. Their work appears in journals such as The Lancet, European Journal of Cancer, British Journal of Cancer, British journal of surgery and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.